SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-030886
Filing Date
2018-12-13
Accepted
2018-12-13 16:35:56
Documents
1
Period of Report
2018-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7027
  Complete submission text file 0000899243-18-030886.txt   8398
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address
Heffernan Michael Thomas (Reporting) CIK: 0001448914 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 181233630